Second Sight Medical (EYES) Surges 300%+ Following FDA Approval
Tweet Send to a Friend
Second Sight Medical (NASDAQ: EYES) surges 337% after the company announced ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
